Today's Daily Dose brings you news about ACADIA's North American License Agreement with Neuren Pharma; upcoming milestones of Akcea; product development agreement between Antares and Pfizer; CryoLife's Q2 results and upbeat outlook; partial clinical hold on Gemphire's Gemcabene, and InspireMD's and Vericel's Q2 financial results.
from RTT - Biotech https://ift.tt/2ALN3W9
via IFTTT
No comments:
Post a Comment